ELV EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
ELV's ev/ebitda is higher than 82% of the last 10 years.
EV/EBITDA History
ELV EV/EBITDA by year
Yearly range of ELV’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 7.7 to 17.9, averaging 12.1.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 8.9 | 11.6 | 14.2 | 13.5 |
| 2025 | 8.5 | 10.3 | 12.0 | 10.5 |
| 2024 | 9.7 | 12.6 | 13.9 | 10.5 |
| 2023 | 10.5 | 12.1 | 13.8 | 12.0 |
| 2022 | 12.2 | 13.4 | 14.5 | 13.6 |
| 2021 | 10.8 | 13.4 | 15.8 | 13.3 |
| 2020 | 7.8 | 10.5 | 12.2 | 11.8 |
| 2019 | 10.6 | 12.5 | 14.2 | 12.0 |
| 2018 | 12.1 | 15.0 | 17.9 | 12.1 |
| 2017 | 8.5 | 10.9 | 13.7 | 13.2 |
| 2016 | 7.7 | 8.5 | 9.2 | 9.0 |
Get notified when ELV EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is ELV EV/EBITDA High or Low Right Now?
Elevance Health Inc.'s EV/EBITDA is currently 13.5, which is historically pricey relative to its 10-year historical range. The 10-year median EV/EBITDA for ELV is approximately 12.2. See all ELV valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.